| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 50.86B | 49.62B | 51.30B | 51.41B | 52.57B | 49.12B |
| Gross Profit | 5.21B | 6.07B | 4.95B | 4.08B | 6.27B | 6.21B |
| EBITDA | 1.85B | 3.01B | 1.53B | 729.00M | 3.07B | 3.07B |
| Net Income | 846.00M | 213.00M | 703.00M | 1.54B | 916.00M | 2.52B |
Balance Sheet | ||||||
| Total Assets | 70.41B | 65.70B | 69.90B | 75.08B | 73.87B | 72.18B |
| Cash, Cash Equivalents and Short-Term Investments | 12.49B | 9.09B | 12.01B | 12.04B | 8.04B | 10.13B |
| Total Debt | 21.13B | 17.33B | 21.51B | 24.46B | 24.75B | 22.69B |
| Total Liabilities | 42.66B | 36.45B | 42.03B | 48.22B | 49.42B | 48.86B |
| Stockholders Equity | 27.75B | 29.19B | 27.86B | 26.86B | 24.45B | 23.31B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 885.00M | 96.00M | -2.91B | -6.13B | 1.82B |
| Operating Cash Flow | 0.00 | 2.60B | 1.21B | -203.00M | -1.51B | 4.50B |
| Investing Cash Flow | 0.00 | -1.37B | 1.71B | 4.20B | -2.72B | -2.75B |
| Financing Cash Flow | 0.00 | -4.39B | -3.19B | -502.00M | 2.02B | -399.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥46.82B | 6.29 | ― | 6.31% | -12.17% | -23.60% | |
67 Neutral | ¥31.83B | 8.82 | ― | 4.13% | -3.15% | 29.33% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
58 Neutral | ¥80.01B | 13.13 | ― | 3.70% | -2.40% | -8.59% | |
55 Neutral | ¥6.02B | 27.37 | ― | ― | -3.27% | -68.97% | |
55 Neutral | ¥36.11B | 13.50 | ― | 5.02% | -12.42% | -56.79% | |
44 Neutral | ¥71.12B | -1.48 | ― | 1.24% | -18.32% | -943.95% |